Maplelane Capital’s KEMET Corporation KEM Stock Holding History

Maplelane Capital’s Portfolio KEM Stock Details KEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1	Closed	-$18	–	184
2018 Q4	$0	Buy	+1	New	+$19	﹤0.01%	192

Other funds holding KEM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Maplelane Capital's KEM Position: Q1 2019 in Review

Maplelane Capital sold out of KEMET Corporation (KEM) in Q1 2019, closing a stake of 1 share — an estimated $18 sold.

Maplelane Capital first reported a position in KEM in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 207 funds tracked by Wall St. Rank hold KEM as of Q1 2019.

Maplelane Capital reported no remaining KEMET Corporation position as of Q1 2019 after selling out during the quarter.
Maplelane Capital sold 1 KEMET Corporation share in Q1 2019, an estimated $18.
Maplelane Capital first reported a position in KEMET Corporation in Q4 2018 and held it in 1 quarter.
Maplelane Capital's KEMET Corporation position peaked at $0 in Q4 2018.
207 funds tracked by Wall St. Rank held KEMET Corporation as of Q1 2019.

Based on Maplelane Capital's 13F filing for Q1 2019, filed 15 May 2019.